Trials / Conditions / Adverse Drug Reactions

Adverse Drug Reactions

17 registered clinical trials studyying Adverse Drug Reactions — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions NCT06456086	First Affiliated Hospital of Kunming Medical University	—
Unknown	Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study. NCT04479553	Zhong Wang	—
Recruiting	Ofloxacin Concentration-toxicity Relationship in the Elderly NCT04496024	Centre Hospitalier Universitaire, Amiens	N/A
Completed	The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children NCT04252326	Saglik Bilimleri Universitesi	N/A
Unknown	The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole NCT04547335	Dokuz Eylul University	—
Unknown	Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Ma NCT04743544	Dokuz Eylul University	—
Unknown	Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study NCT03640884	Zhong Wang	—
Completed	Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluat NCT04279470	Groupe Hospitalier Pitie-Salpetriere	—
Completed	Pharmacogenetic Testing Among Home Health Patients NCT02378220	Genelex Corporation	N/A
Completed	YouScript IMPACT Registry NCT02191358	Genelex Corporation	—
Completed	Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study NCT02239237	Zhong Wang	—
Completed	Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Olde NCT02097654	University College Cork	N/A
Completed	Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years NCT01764204	China Academy of Chinese Medical Sciences	—
Completed	The Effect of Medication Review in High-risk Emergency Department Patients NCT02122965	University of British Columbia	N/A
Completed	Adverse Drug Event Prevention Using Structured Pharmacist Review NCT01467128	University College Cork	Phase 4
Completed	A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women NCT01354730	Adimmune Corporation	—
Completed	Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward NCT01058122	University of Zurich	—